Use of electronic health record data from diverse primary care practices to identify and characterize patients’ prescribed common medications
暂无分享,去创建一个
Kari A Stephens | Laura-Mae Baldwin | Gina A. Keppel | Allison M Cole | Imara West | Gina A Keppel | Ken Thummel | A. Cole | K. Stephens | L. Baldwin | Kenneth T. Thummel | Imara West
[1] L Keoki Williams,et al. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. , 2004, Diabetes care.
[2] G. Lippi,et al. Statins for Primary Prevention of Cardiovascular Disease. , 2017, Trends in pharmacological sciences.
[3] Ross Upshur,et al. Short report: managing anticoagulation. Comparison of results at three primary care centres. , 2003, Canadian family physician Medecin de famille canadien.
[4] S. Lines,et al. Dipstick test for myoglobinuria , 2008, BMJ : British Medical Journal.
[5] E. Devine,et al. Frequency and Causes of Overanticoagulation and Underanticoagulation in Patients Treated with Warfarin , 2004, Pharmacotherapy.
[6] Douglas K Owens,et al. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement. , 2016, JAMA.
[7] Marshall Godwin,et al. Identification of Dyslipidemic Patients Attending Primary Care Clinics Using Electronic Medical Record (EMR) Data from the Canadian Primary Care Sentinel Surveillance Network (CPCSSN) Database , 2017, Journal of Medical Systems.
[8] A. Forster,et al. Anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: a systematic review and meta-analysis , 2008, Canadian Medical Association Journal.
[9] D Kalra,et al. Electronic health records: new opportunities for clinical research , 2013, Journal of internal medicine.
[10] Kari A. Stephens,et al. LC Data QUEST: A Technical Architecture for Community Federated Clinical Data Sharing , 2012, AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science.
[11] S. Ward,et al. A systematic review and economic evaluation of statins for the prevention of coronary events. , 2007, Health technology assessment.
[12] Kari A. Stephens,et al. Implementing partnership-driven clinical federated electronic health record data sharing networks , 2016, Int. J. Medical Informatics.
[13] J. Hallas,et al. Lipid-Lowering Drugs and Risk of Myopathy: A Population-Based Follow-Up Study , 2001, Epidemiology.
[14] R Peto,et al. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. , 2008, Lancet.
[15] Richard Platt,et al. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. , 2004, JAMA.
[16] K. Fahrbach,et al. Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis. , 2004, Chest.
[17] Viju Raghupathi,et al. Big data analytics in healthcare: promise and potential , 2014, Health Information Science and Systems.
[18] D G Cook,et al. Evolution of statin prescribing 1994–2001: a case of agism but not of sexism? , 2003, Heart.
[19] J. Walkup,et al. Studying Prescription Drug Use and Outcomes With Medicaid Claims Data: Strengths, Limitations, and Strategies , 2007, Medical care.
[20] S. Ebrahim,et al. Reduced dietary salt for the prevention of cardiovascular disease (Review) , 2016 .
[21] Yuchiao Chang,et al. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? , 2003, JAMA.
[22] S. Brunak,et al. Mining electronic health records: towards better research applications and clinical care , 2012, Nature Reviews Genetics.
[23] L. Thorpe,et al. Innovations in Population Health Surveillance: Using Electronic Health Records for Chronic Disease Surveillance. , 2017, American journal of public health.
[24] Lucy Savitz,et al. Challenges in Using Electronic Health Record Data for CER: Experience of 4 Learning Organizations and Solutions Applied , 2013, Medical care.
[25] G. Nichols,et al. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients. , 2007, Clinical therapeutics.